Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
13F holders, Q4 2024 (December 31)9holders
1new positions
2sold out
$2.20avg. 13F price*
At the end of Q4 2024, 9 institutions reported holding Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were Nomura Holdings Inc. ($19.9M), New York State Common Retirement Fund ($6.7M) and BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($4.9M).
- Company
- Sarepta Therapeutics Inc. (srpt 1.25 09/15/27)
- CUSIP
- 803607AD2
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.8M |
| Exits | 2 | $12.4M |
All 13F filers, Q3 2024 → Q4 2024: 4,147,462 shares bought and 11,197,500 shares sold, net −7,050,038 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Nomura Holdings Inc. | 0.11% | Add +2.8% | 163,352 | $19.9M |
| New York State Common Retirement Fund | 0.01% | Add +36.2% | 6,123,000 | $6.7M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 4,400,000 | $4.9M |
| Ofi Invest Asset Management | 0.10% | — | 4,000,000 | $4.3M |
| Toronto Dominion Bank | 0.01% | New | 2,500,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | Reduce -37.5% | 500,000 | $551K |
| Choreo, LLC | 0.00% | Add +100.0% | 34,000 | $37K |
| Stonegate Investment Group, LLC | 0.00% | No change | 13,000 | $14K |
| Rothschild Investment LLC | 0.00% | No change | 1,000 | $1K |
"% of holder's portfolio" is SAREPTA THERAPEUTICS INC (SRPT 1.25 09/15/27)'s weight in each manager's 13F, not the share of Sarepta Therapeutics Inc. (srpt 1.25 09/15/27) the manager owns.